Objective: The indications for the Med-El Vibrant Soundbridge, currently limited to patients with sensorineural hearing loss and normal middle ear function, have been extended to include patients with conductive or mixed hearing loss because of severe acquired or congenital ossicular chain defects. Patients with congenital aural atresia have combined malformations of the external auditory canal and the middle ear, often accompanied by severe mixed hearing impairment. Long-term results of traditional surgical techniques for treatment of congenital aural atresia show a persistent air-bone gap in most patients, suggesting that new and better techniques for hearing rehabilitation in these patients would be of value. This study demonstrates that...
Introduction: External auditory canal atresia is a rare congenital disorder which affects one or bo...
Congenital external auditory canal atresia is a disorder with a prevalence of one in 10 000-20 000 l...
PURPOSE To review functional and subjective benefit after implantation of an active transcutaneous b...
Abstract OBJECTIVE: The indications for the Med-El Vibrant Soundbridge, currently limited to patien...
OBJECTIVE: To evaluate the long-term outcomes of the first 5 infants and 9 children with congenital...
To evaluate the long-term outcomes of the first 5 infants and 9 children with congenital aural atres...
AbstractOsseous atresia and chronic otitis media are diseases benefit with middle ear implants. Surg...
To evaluate retrospectively the long-term safety and efficacy of the first 50 patients, all sufferin...
AbstractObjectiveTo report use of the Vibrant Soundbridge (VSB) in patients with congenital deformat...
Early clinical findings are reported for subjects implanted with the Vibrant Med-El Soundbridge (VSB...
Introduction Hearing loss is the most common clinical finding in patients with malformation of the e...
Purpose. The aim of this paper is to illustrate imaging features of patients affected by congenital ...
BACKGROUND: There is no consensus on treatment of patients with congenital unilateral aural atresia....
PURPOSE: The aim of this paper is to illustrate imaging features of patients affected by congenit...
Copyright © 2015 Giovanni Bianchin et al. This is an open access article distributed under the Creat...
Introduction: External auditory canal atresia is a rare congenital disorder which affects one or bo...
Congenital external auditory canal atresia is a disorder with a prevalence of one in 10 000-20 000 l...
PURPOSE To review functional and subjective benefit after implantation of an active transcutaneous b...
Abstract OBJECTIVE: The indications for the Med-El Vibrant Soundbridge, currently limited to patien...
OBJECTIVE: To evaluate the long-term outcomes of the first 5 infants and 9 children with congenital...
To evaluate the long-term outcomes of the first 5 infants and 9 children with congenital aural atres...
AbstractOsseous atresia and chronic otitis media are diseases benefit with middle ear implants. Surg...
To evaluate retrospectively the long-term safety and efficacy of the first 50 patients, all sufferin...
AbstractObjectiveTo report use of the Vibrant Soundbridge (VSB) in patients with congenital deformat...
Early clinical findings are reported for subjects implanted with the Vibrant Med-El Soundbridge (VSB...
Introduction Hearing loss is the most common clinical finding in patients with malformation of the e...
Purpose. The aim of this paper is to illustrate imaging features of patients affected by congenital ...
BACKGROUND: There is no consensus on treatment of patients with congenital unilateral aural atresia....
PURPOSE: The aim of this paper is to illustrate imaging features of patients affected by congenit...
Copyright © 2015 Giovanni Bianchin et al. This is an open access article distributed under the Creat...
Introduction: External auditory canal atresia is a rare congenital disorder which affects one or bo...
Congenital external auditory canal atresia is a disorder with a prevalence of one in 10 000-20 000 l...
PURPOSE To review functional and subjective benefit after implantation of an active transcutaneous b...